-
1
-
-
0031065108
-
Down-regulation of FcεRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody
-
D.W. MacGlashan Jr., B.S. Bochner, D.C. Adelman, P.M. Jardieu, A. Togias, and J. McKenzie-White Down-regulation of FcεRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody J Immunol 158 1997 1438 1445
-
(1997)
J Immunol
, vol.158
, pp. 1438-1445
-
-
MacGlashan Jr., D.W.1
Bochner, B.S.2
Adelman, D.C.3
Jardieu, P.M.4
Togias, A.5
McKenzie-White, J.6
-
2
-
-
0033136728
-
Down-regulation of human basophil IgE and FcεRIα surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo
-
S.S. Saini, D.W. MacGlashan Jr., S.A. Sterbinsky, A. Togias, D.C. Adelman, and L.M. Lichtenstein Down-regulation of human basophil IgE and FcεRIα surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo J Immunol 162 1999 5624 5630
-
(1999)
J Immunol
, vol.162
, pp. 5624-5630
-
-
Saini, S.S.1
MacGlashan Jr., D.W.2
Sterbinsky, S.A.3
Togias, A.4
Adelman, D.C.5
Lichtenstein, L.M.6
-
3
-
-
0031571714
-
Cutaneous injection of RANTES causes eosinophil recruitment: Comparison of nonallergic and allergic human subjects
-
L.A. Beck, S. Dalke, K.M. Leiferman, C.A. Bickel, R. Hamilton, and H. Rosen Cutaneous injection of RANTES causes eosinophil recruitment: comparison of nonallergic and allergic human subjects J Immunol 159 1997 2962 2972
-
(1997)
J Immunol
, vol.159
, pp. 2962-2972
-
-
Beck, L.A.1
Dalke, S.2
Leiferman, K.M.3
Bickel, C.A.4
Hamilton, R.5
Rosen, H.6
-
5
-
-
0001526474
-
Anti-IgE infusions reduces skin test reactivity
-
A. Togias, J. Corren, G. Shapiro, J.D. Reiman, A. von Schlegell, and T.G. Wighton Anti-IgE infusions reduces skin test reactivity J Allergy Clin Immunol 101 suppl 1998 S171
-
(1998)
J Allergy Clin Immunol
, vol.101
-
-
Togias, A.1
Corren, J.2
Shapiro, G.3
Reiman, J.D.4
Von Schlegell, A.5
Wighton, T.G.6
-
6
-
-
4444347260
-
A randomized double-blind, placebo-controlled study to assess the effects of omalizumab (a humanized monoclonal anti-IgE antibody) on early- and late-phase skin reactions and cellular infiltrate after multiple intradermal allergen challenges
-
Y.-E Ong, A. Menzies-Gow, J. Matthews, and A.B. Kay A randomized double-blind, placebo-controlled study to assess the effects of omalizumab (a humanized monoclonal anti-IgE antibody) on early- and late-phase skin reactions and cellular infiltrate after multiple intradermal allergen challenges J Allergy Clin Immunol 113 suppl 2004 S84
-
(2004)
J Allergy Clin Immunol
, vol.113
-
-
Ong, Y.-E.1
Menzies-Gow, A.2
Matthews, J.3
Kay, A.B.4
-
7
-
-
0030956903
-
The effect of an anti-IgE monoclonal antibody on the early- and late- phase responses to allergen inhalation in asthmatic subjects
-
J.V. Fahy, H.E. Fleming, H.H. Wong, J.T. Liu, J.Q. Su, and J. Reimann The effect of an anti-IgE monoclonal antibody on the early- and late- phase responses to allergen inhalation in asthmatic subjects Am J Respir Crit Care Med 155 1997 1828 1834
-
(1997)
Am J Respir Crit Care Med
, vol.155
, pp. 1828-1834
-
-
Fahy, J.V.1
Fleming, H.E.2
Wong, H.H.3
Liu, J.T.4
Su, J.Q.5
Reimann, J.6
-
8
-
-
8244226656
-
Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response
-
L.P. Boulet, K.R. Chapman, J. Cote, S. Kalra, R. Bhagat, and V.A. Swystun Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response Am J Respir Crit Care Med 155 1997 1835 1840
-
(1997)
Am J Respir Crit Care Med
, vol.155
, pp. 1835-1840
-
-
Boulet, L.P.1
Chapman, K.R.2
Cote, J.3
Kalra, S.4
Bhagat, R.5
Swystun, V.A.6
-
9
-
-
0037434895
-
Effect of anti-IgE therapy in patients with peanut allergy
-
D.Y. Leung, H.A. Sampson, J.W. Yunginger, A.W. Burks Jr., L.C. Schneider, and C.H. Wortel Effect of anti-IgE therapy in patients with peanut allergy N Engl J Med 348 2003 986 993
-
(2003)
N Engl J Med
, vol.348
, pp. 986-993
-
-
Leung, D.Y.1
Sampson, H.A.2
Yunginger, J.W.3
Burks Jr., A.W.4
Schneider, L.C.5
Wortel, C.H.6
|